StockData
Intensity Therapeutics, Inc. logo

Intensity Therapeutics, Inc. (INTS) income statement

INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$2.64−0.03 (-1.12%)

Close on Nov 18, 2026Market cap $8.62MP/E –Yield –

Intensity Therapeutics, Inc. financial ratios

See a number that looks wrong?